-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $53

Benzinga·11/10/2026 16:50:56
Listen to the news
TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and lowers the price target from $84 to $53.